A federal judge in Maine issued an order blocking the Department of Health and Human Services from implementing the latest 340B drug rebate pilot program ahead of its planned Jan. 1 effective date. The court action stems from legal challenges brought by drugmakers who argued the pilot exceeded statutory authority. The pause prevents HHS from moving forward with this iteration while litigation continues, creating immediate uncertainty for hospitals, drug manufacturers and federal pricing policy enforcement.